Safety of Pioglitazone for Hematoma Resolution In Intracerebral Hemorrhage (SHRINC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00827892
Recruitment Status : Completed
First Posted : January 23, 2009
Last Update Posted : October 2, 2015
Information provided by (Responsible Party):
Nicole Gonzales, The University of Texas Health Science Center, Houston